To evaluate the efficacy of Go-Dugdha and Mahish-Dugdha paan in management of Nidranash w.s.r. to Insomnia in Adults

In today’s era contemporary therapeutic variety of sedative are prescribed for managing insomnia. These tranquilizers initially give substantial aid in insomnia but permanent and extensive use may stimulate various lethal effects including drug addiction. Various studies have noted in year 2016, insomnia to be quite a common condition with symptoms present in about 33-50% of the adult population. The prevalence, however, ranges from 10 to 15% among the general population, with higher rates seen among divorced, separated, or widowed people, older ages, female gender, white population, and in the presence of co-morbid medical or psychiatric illness. About 30% of all adults complain of occasional insomnia and 10% of chronic insomnia, of whom 40% may have a psychiatric illness. Despite these high prevalence rates, evidence suggests that insomnia is mostly under-recognized, under-diagnosed, and under-treated, with the condition continuing to remain persistent in 50-85% of individuals over follow-up intervals of one to several years. Insomnia patients are more likely to visit hospitals and physicians, have increased absenteeism, make errors or have accidents at work, and have more fatal road accidents. There is also an increased risk for depression, anxiety, substance use, suicide, and possible immune dysfunction. Hence rather than using sedative on large scale, Go-Dugdha and Mahish Dugdha which is already described in classical text can be preferred for treating "nidranash". If it’s efficacy is proved through this study, this will be beneficial for larger population.